266 related articles for article (PubMed ID: 10718501)
21. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.
Christen WG; Glynn RJ; Chew EY; Buring JE
Ophthalmology; 2009 Dec; 116(12):2386-92. PubMed ID: 19815293
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
23. Aspirin administered to women at 100 mg every other day produces less platelet inhibition than aspirin administered at 81 mg per day: implications for interpreting the women's health study.
Swaim L; Hillman RS
J Thromb Thrombolysis; 2009 Jul; 28(1):94-100. PubMed ID: 18685810
[TBL] [Abstract][Full Text] [Related]
24. Low dose aspirin and cognitive function in the women's health study cognitive cohort.
Kang JH; Cook N; Manson J; Buring JE; Grodstein F
BMJ; 2007 May; 334(7601):987. PubMed ID: 17468120
[TBL] [Abstract][Full Text] [Related]
25. Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncompliance.
Cook NR; Cole SR; Buring JE
Eur J Epidemiol; 2012 Jun; 27(6):431-8. PubMed ID: 22699516
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.
Cook NR; Mora S; Ridker PM
J Am Coll Cardiol; 2018 Jul; 72(3):287-296. PubMed ID: 30012322
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial of aspirin, vitamin E raises questions for future chemoprevention studies.
Hayasaka E
J Natl Cancer Inst; 2005 Sep; 97(17):1242-3. PubMed ID: 16145040
[No Abstract] [Full Text] [Related]
28. Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
J Cardiovasc Risk; 1995 Apr; 2(2):137-42. PubMed ID: 7606650
[TBL] [Abstract][Full Text] [Related]
29. Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study.
Kurth T; Barr RG; Gaziano JM; Buring JE
Thorax; 2008 Jun; 63(6):514-8. PubMed ID: 18339679
[TBL] [Abstract][Full Text] [Related]
30. Aspirin and age-related macular degeneration.
de Jong PT
Ophthalmology; 2010 Jun; 117(6):1279-80; author reply 1280. PubMed ID: 20522343
[No Abstract] [Full Text] [Related]
31. [Primary prevention of cardiovascular disease with acetylsalicylic acid: in high-risk patients].
Kappelle LJ
Ned Tijdschr Geneeskd; 2005 Apr; 149(16):853-4. PubMed ID: 15868987
[TBL] [Abstract][Full Text] [Related]
32. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
33. Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view.
Buring JE; Hennekens CH
Ann Epidemiol; 1994 Mar; 4(2):111-4. PubMed ID: 8205276
[TBL] [Abstract][Full Text] [Related]
34. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
[TBL] [Abstract][Full Text] [Related]
35. [The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice].
De Caterina R
Ital Heart J Suppl; 2001 Jun; 2(6):681-4. PubMed ID: 11460845
[No Abstract] [Full Text] [Related]
36. [Results of the Women's Health Study].
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 14):54-5. PubMed ID: 16184856
[No Abstract] [Full Text] [Related]
37. Low-dose aspirin in the primary prevention of rheumatoid arthritis: the Women's Health Study.
Shadick NA; Karlson EW; Cook NR; Maher NE; Buring JE; Lee IM
Arthritis Care Res (Hoboken); 2010 Apr; 62(4):545-50. PubMed ID: 20391510
[TBL] [Abstract][Full Text] [Related]
38. Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice.
Battistoni A; Mastromarino V; Volpe M
Clin Cardiol; 2015 Jun; 38(6):387-94. PubMed ID: 25873555
[TBL] [Abstract][Full Text] [Related]
39. Low-dose aspirin for migraine prophylaxis in women.
Benseñor IM; Cook NR; Lee IM; Chown MJ; Hennekens CH; Buring JE
Cephalalgia; 2001 Apr; 21(3):175-83. PubMed ID: 11442551
[TBL] [Abstract][Full Text] [Related]
40. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study.
McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH;
J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
